tiprankstipranks
Trending News
More News >

JCR Pharmaceuticals Reports Significant Decline in Financial Performance

Story Highlights
JCR Pharmaceuticals Reports Significant Decline in Financial Performance

Confident Investing Starts Here:

An update from JCR Pharmaceuticals Co., Ltd. ( (JP:4552) ) is now available.

JCR Pharmaceuticals’ latest financial results reveal a significant decline in performance, with net sales dropping by 23.2% and a shift from profit to a loss in operating and ordinary profits. The company’s comprehensive income also fell sharply, indicating potential challenges in maintaining its previous growth trajectory.

More about JCR Pharmaceuticals Co., Ltd.

JCR Pharmaceuticals Co., Ltd. operates in the pharmaceutical industry with a focus on the development and manufacturing of pharmaceutical products. The company is listed on the Tokyo Stock Exchange and is part of the general business category.

YTD Price Performance: -6.10%

Average Trading Volume: 369,071

Technical Sentiment Consensus Rating: Strong Buy

Current Market Cap: Yen70.54B

For detailed information about 4552 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App